(Q72390630)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6088887 AND SRC:MED&resulttype=core&format=json

26 October 2019

title

Renin- and non-renin-mediated antihypertensive actions of converting enzyme inhibitors (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6088887 AND SRC:MED&resulttype=core&format=json

26 October 2019

Renin- and non-renin–mediated antihypertensive actions of converting enzyme inhibitors (English)

1 reference

2 August 2023

1 reference

2 August 2023

author name string

R. M. Zusman

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:6088887

2 August 2023

language of work or name

English

0 references

publication date

1 June 1984

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6088887 AND SRC:MED&resulttype=core&format=json

full work available at URL

26 October 2019

https://api.elsevier.com/content/article/PII:S0085253815332282?httpAccept=text/xml

1 reference

https://api.elsevier.com/content/article/PII:S0085253815332282?httpAccept=text/plain

2 August 2023

1 reference

2 August 2023

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6088887 AND SRC:MED&resulttype=core&format=json

26 October 2019

volume

25

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6088887 AND SRC:MED&resulttype=core&format=json

26 October 2019

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6088887 AND SRC:MED&resulttype=core&format=json

26 October 2019

page(s)

969-983

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6088887 AND SRC:MED&resulttype=core&format=json

The renin-angiotensin system and hypertension

26 October 2019

cites work

1 reference

7 January 2021

Angiotensin-Converting Enzyme and the Regulation of Vasoactive Peptides

1 reference

7 January 2021

Complete purification of dog renal renin

1 reference

7 January 2021

Large scale purification of hog renin. Physicochemical characterization

1 reference

7 January 2021

Renin-specific antibody for study of cardiovascular homeostasis

1 reference

7 January 2021

The preparation, purification, and amino acid sequence of a polypeptide renin substrate

1 reference

7 January 2021

Kinetics of the reaction of renin with nine synthetic peptide substrates

1 reference

7 January 2021

Specific inhibition of renin by an angiotensinogen analog: studies in sodium depletion and renin-dependent hypertension

1 reference

7 January 2021

A substrate analog inhibitor of renin that is effective in vivo

1 reference

7 January 2021

Potent new inhibitors of human renin

1 reference

7 January 2021

Novel renin inhibitors containing the amino acid statine

1 reference

7 January 2021

A specific competitive antagonist of the vascular action of angiotensin. II

1 reference

7 January 2021

The existence of two forms of hypertensin

1 reference

7 January 2021

The amino acid composition of hypertensin II and its biochemical relationship to hypertensin I.

1 reference

7 January 2021

Differentiation between two forms of angiotonin by means of spirally cut strips of rabbit aorta

1 reference

7 January 2021

Conversion of angiotensin I to angiotensin II.

1 reference

7 January 2021

Fate of angiotensin I in the circulation

1 reference

7 January 2021

The disappearance of bradykinin and eledoisin in the circulation and vascular beds of the cat

1 reference

7 January 2021

Conversion of Angiotensin I to Angiotensin II by Cell-free Extracts of Dog Lung

1 reference

7 January 2021

Activity of various fractions of bradykinin potentiating factor against angiotensin I converting enzyme

1 reference

7 January 2021

Isolation of bradykinin-potentiating peptides from Bothrops jararaca venom

1 reference

7 January 2021

Angiotensin converting enzyme (ACE) inhibitors

1 reference

7 January 2021

Design of new antihypertensive drugs: Potent and specific inhibitors of angiotensin-converting enzyme

1 reference

7 January 2021

Binding of the by-product analog benzylsuccinic acid by carboxypeptidase A

1 reference

7 January 2021

Design of potent competitive inhibitors of angiotensin-converting enzyme. Carboxyalkanoyl and mercaptoalkanoyl amino acids

1 reference

7 January 2021

Inhibitors of angiotensin-converting enzyme

1 reference

7 January 2021

Clinical experience with blockade of the renin-angiotensin-aldosterone system by an oral converting-enzyme inhibitor (SQ 14,225, captopril) in hypertensive patients

1 reference

7 January 2021

Effects of angiotensin I-converting enzyme inhibitor, SQ 14225, in nomal men

1 reference

7 January 2021

Captopril-induced changes in prostaglandin production: relationship to vascular responses in normal man

1 reference

7 January 2021

Converting enzyme inhibition in essential hypertension: the hypotensive response does not reflect only reduced angiotensin II formation

1 reference

7 January 2021

Differences in response to the peptidyldipeptide hydrolase inhibitors SQ 20,881 and SQ 14,225 in normal-renin essential hypertension

1 reference

7 January 2021

Long-term effects of captopril (SQ14 225) on blood-pressure and hormone levels in essential hypertension

1 reference

7 January 2021

Acute changes in blood pressure and vasoactive hormones after captopril in hypertensive patients

1 reference

7 January 2021

Central and peripheral effects of bradykinin and prostaglandin E2 on blood pressure in conscious rats

1 reference

7 January 2021

Hormonal Changes with Long-Term Converting-Enzyme Inhibition by Captopril in Essential Hypertension

1 reference

7 January 2021

Endocrine profile in the long-term phase of converting-enzyme inhibition

1 reference

7 January 2021

Vasodepressor property of the converting enzyme inhibitor captopril (SQ 14 225): the role of factors other than renin-angiotensin blockade in the rat

1 reference

7 January 2021

Converting enzyme inhibitor and saralasin infusion in rats. Evidence for an additional vasodepressor property of converting enzyme inhibitor

1 reference

7 January 2021

Converting enzyme inhibition during chronic angiotensin II infusion in rats. Evidence against a nonangiotensin mechanism

1 reference

7 January 2021

Absence of blood-pressure lowering effect of captopril in anephric patients

1 reference

7 January 2021

Does captopril lower blood pressure in anephric patients?

1 reference

7 January 2021

Effects of an angiotensin-converting enzyme inhibitor (captopril) on blood pressure in anephric subjects

1 reference

7 January 2021

Evidence that the acute hypotensive effect of captopril in dogs is not wholly explained by a reduction of plasma angiotensin II and its direct vasoconstrictor effect

1 reference

7 January 2021

Haemodynamic Effects of Captopril in Hypertensive Patients: Comparison with Saralasin

1 reference

7 January 2021

The effect of converting enzyme inhibition with SQ20,881 on plasma and urinary kinins, prostaglandin E, and angiotensin II in hypertensive man

1 reference

7 January 2021

Increase in Prostaglandins during Converting Enzyme Inhibition

1 reference

7 January 2021

Role of prostaglandin in the antihypertensive mechanism of captopril in low renin hypertension

1 reference

7 January 2021

Contribution of prostaglandins to the antihypertensive action of captopril in essential hypertension

1 reference

7 January 2021

Acute hypotensive effect of captopril in man modified by prostaglandin synthesis inhibition

1 reference

7 January 2021

Hormonal responses to long-term converting enzyme inhibition in hypertensive patients

1 reference

7 January 2021

Acute haemodynamic and hormonal effects of captopril are diminished by indomethacin

1 reference

7 January 2021

Evidence from a dual action of converting enzyme inhibitor on blood pressure in normal man

1 reference

7 January 2021

The effect of prostaglandin synthesis inhibition of the acute blood pressure reduction by captopril in pentobarbital-anaesthetized rats

1 reference

7 January 2021

The release and fate of vaso-active hormones in the circulation

1 reference

7 January 2021

Thromboxanes: selective biosynthesis and distinct biological properties

1 reference

7 January 2021

Prostacyclin is a circulating hormone

1 reference

7 January 2021

Prostaglandin biosynthesis by rabbit renomedullary interstitial cells in tissue culture. Stimulation by angiotensin II, bradykinin, and arginine vasopressin

1 reference

7 January 2021

Identification of an angiotensin receptor in rabbit renomedullary interstitial cells in tissue culture. Correlation with prostaglandin biosynthesis

1 reference

7 January 2021

Prostacyclin mediates the potentiated hypotensive effect of bradykinin following captopril treatment

1 reference

7 January 2021

The effects of kininase II inhibition by SQ 14225 on kidney kallikrein-kinin and prostaglandin systems in conscious dogs

1 reference

7 January 2021

The role of calcium in the stimulation of prostaglandin synthesis by vasopressin in rabbit renal-medullary interstitial cells in tissue culture

1 reference

7 January 2021

Captopril-Induced Functional Renal Insufficiency in Patients with Bilateral Renal-Artery Stenoses or Renal-Artery Stenosis in a Solitary Kidney

1 reference

7 January 2021

Inhibition of angiotensin-converting enzyme in renal-transplant recipients with hypertension

1 reference

7 January 2021

Transient anuria following administration of angiotensin I-converting enzyme inhibitor (SQ 14225) in a patient with renal artery stenosis of the solitary kidney successfully treated with renal autotransplantation

1 reference

7 January 2021

Reversible renal failure during treatment with captopril

1 reference

7 January 2021

Increased Glomerular Filtration Rate after Converting-Enzyme Inhibition in Essential Hypertension

1 reference

7 January 2021

Renal response to angiotensin-converting enzyme inhibition

1 reference

7 January 2021

Captopril and Renal Autoregulation

1 reference

7 January 2021

The effect of SQ14,225 on systolic blood pressure and urinary excretion of vasopressin in the developing spontaneously hypertensive rat

1 reference

7 January 2021

Reduction of plasma and urinary vasopressin during treatment of severe hypertension by captopril

1 reference

7 January 2021

Comparison of the hormonal and renal effects of captopril in severe essential and renovascular hypertension

1 reference

7 January 2021

Captopril (SQ 14225) depresses drinking and aldosterone in rats lacking vasopressin

1 reference

7 January 2021

Modification of arterial baroreflexes by captopril in essential hypertension

1 reference

7 January 2021

Mechanism of Action of Calcium-Channel-Blocking Agents

1 reference

7 January 2021

Captopril combined with thiazide lowers renin substrate concentration: implications for methodology in renin assays

1 reference

7 January 2021

Captopril-associated neutropenia. Who is at risk?

1 reference

7 January 2021

Effect of captopril on uterine blood flow and prostaglandin E synthesis in the pregnant rabbit

1 reference

7 January 2021

Captopril: an update review of its pharmacological properties and therapeutic efficacy in congestive heart failure

1 reference

7 January 2021

Prostaglandins and water excretion

1 reference

7 January 2021

Hemodynamic effects of a competitive renin inhibitory peptide in humans: evidence for multiple mechanisms of action

14

1 reference

Hormonal responses to angiotensin blockade. Comparison between receptor antagonism and converting enzyme inhibition

2 August 2023

48

1 reference

Responses of the renin-angiotensin system and kallikrein-kinin system to sodium and converting enzyme inhibitor (SQ 14,225)

2 August 2023

53

1 reference

Antihypertensive action of captopril in angiotensin-salt hypertension

2 August 2023

60

1 reference

Endocrine-type antihypertensive function of renomedullary interstitial cells

2 August 2023

84

1 reference

Chronic blockade of angiotensin II formation during sodium deprivation

2 August 2023

118

1 reference

2 August 2023

Identifiers

DOI

10.1038/KI.1984.119

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6088887 AND SRC:MED&resulttype=core&format=json

26 October 2019

1 reference